These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
125 related items for PubMed ID: 2965719
1. Double-blind placebo-controlled study of loratadine, mequitazine, and placebo in the symptomatic treatment of seasonal allergic rhinitis. Skassa-Brociek W, Bousquet J, Montes F, Verdier M, Schwab D, Lherminier M, Michel FB. J Allergy Clin Immunol; 1988 Apr; 81(4):725-30. PubMed ID: 2965719 [Abstract] [Full Text] [Related]
6. Safety and efficacy of loratadine (Sch-29851): a new non-sedating antihistamine in seasonal allergic rhinitis. Dockhorn RJ, Bergner A, Connell JT, Falliers CJ, Grabiec SV, Weiler JM, Shellenberger MK. Ann Allergy; 1987 Jun; 58(6):407-11. PubMed ID: 2954497 [Abstract] [Full Text] [Related]
7. Loratadine (SCH29851) 40 mg once daily versus terfenadine 60 mg twice daily in the treatment of seasonal allergic rhinitis. Bruttmann G, Pedrali P. J Int Med Res; 1987 Jun; 15(2):63-70. PubMed ID: 2884152 [Abstract] [Full Text] [Related]
8. A multicentric study of loratadine, terfenadine and placebo in patients with seasonal allergic rhinitis. Horak F, Bruttmann G, Pedrali P, Weeke B, Frølund L, Wolff HH, Christophers E. Arzneimittelforschung; 1988 Jan; 38(1):124-8. PubMed ID: 2896508 [Abstract] [Full Text] [Related]
10. Efficacy of an oral antihistamine, loratadine, as compared with a nasal steroid spray, beclomethasone dipropionate, in seasonal allergic rhinitis. Frølund L. Clin Otolaryngol Allied Sci; 1991 Dec; 16(6):527-31. PubMed ID: 1685945 [Abstract] [Full Text] [Related]
11. Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: effects after controlled ragweed pollen challenge in an environmental exposure unit. Day JH, Briscoe M, Widlitz MD. J Allergy Clin Immunol; 1998 May; 101(5):638-45. PubMed ID: 9600501 [Abstract] [Full Text] [Related]
12. A multicentre study of loratadine, clemastine and placebo in patients with perennial allergic rhinitis. Frølund L, Etholm B, Irander K, Johannessen TA, Odkvist L, Ohlander B, Weeke B. Allergy; 1990 May; 45(4):254-61. PubMed ID: 2143361 [Abstract] [Full Text] [Related]
13. Comparative outdoor study of the efficacy, onset and duration of action, and safety of cetirizine, loratadine, and placebo for seasonal allergic rhinitis. Meltzer EO, Weiler JM, Widlitz MD. J Allergy Clin Immunol; 1996 Feb; 97(2):617-26. PubMed ID: 8621847 [Abstract] [Full Text] [Related]
14. Loratadine. A preliminary review of its pharmacodynamic properties and therapeutic efficacy. Clissold SP, Sorkin EM, Goa KL. Drugs; 1989 Jan; 37(1):42-57. PubMed ID: 2523301 [Abstract] [Full Text] [Related]
15. Efficacy and safety of loratadine suspension in the treatment of children with allergic rhinitis. Boner AL, Miglioranzi P, Richelli C, Marchesi E, Andreoli A. Allergy; 1989 Aug; 44(6):437-41. PubMed ID: 2572182 [Abstract] [Full Text] [Related]
16. [Loratadine in the treatment of seasonal allergic rhinitis]. Buko Z, Siergiejko Z, Chyrek-Borowska S. Otolaryngol Pol; 1994 Aug; 48(5):428-34. PubMed ID: 7808748 [Abstract] [Full Text] [Related]
17. A randomized, double-blind, placebo-controlled study comparing the efficacy and safety of ebastine (20 mg and 10 mg) to loratadine 10 mg once daily in the treatment of seasonal allergic rhinitis. Hampel F, Howland W, Van Bavel J, Ratner P. J Investig Allergol Clin Immunol; 2004 Aug; 14(1):56-63. PubMed ID: 15160443 [Abstract] [Full Text] [Related]
18. Treatment of hay fever with loratadine--a new non-sedating antihistamine. Irander K, Odkvist LM, Ohlander B. Allergy; 1990 Feb; 45(2):86-91. PubMed ID: 2138436 [Abstract] [Full Text] [Related]
19. Efficacy of loratadine versus placebo in the prophylactic treatment of seasonal allergic rhinitis. Dolovich J, Moote DW, Mazza JA, Clermont A, PetitClerc C, Danzig M. Ann Allergy; 1994 Sep; 73(3):235-9. PubMed ID: 8092558 [Abstract] [Full Text] [Related]
20. A randomized, double-blind, parallel-group study, comparing the efficacy and safety of rupatadine (20 and 10 mg), a new PAF and H1 receptor-specific histamine antagonist, to loratadine 10 mg in the treatment of seasonal allergic rhinitis. Saint-Martin F, Dumur JP, Pérez I, Izquierdo I, French Rupatadine-Rhinitis Study Group. J Investig Allergol Clin Immunol; 2004 Sep; 14(1):34-40. PubMed ID: 15160440 [Abstract] [Full Text] [Related] Page: [Next] [New Search]